Published in Drugs on May 01, 1986
Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. AAPS J (2005) 1.01
The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure. Vasc Health Risk Manag (2006) 0.76
{2-Hydr-oxy-3-[4-(2-methoxy-ethyl)-phen-oxy]prop-yl}isopropyl-ammonium hemisuccinate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers. Br J Clin Pharmacol (1993) 0.75
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs (1982) 3.34
Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs (1988) 2.94
Midazolam. A review of its pharmacological properties and therapeutic use. Drugs (1984) 2.60
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs (1987) 2.54
Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs (1990) 2.52
Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs (1989) 2.41
Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs (1990) 2.29
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1988) 2.27
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 2.26
Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Drugs (1985) 2.26
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs (1977) 2.17
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs (1978) 2.12
Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs (1983) 2.02
Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs (1991) 1.96
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1993) 1.95
Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1975) 1.93
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs (1982) 1.87
Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs (1995) 1.81
Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs (1997) 1.81
Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Drugs (1993) 1.73
Pyrazolone derivatives. Drugs (1986) 1.72
Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs (1978) 1.72
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1983) 1.71
Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1975) 1.69
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1985) 1.69
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs (1980) 1.67
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1984) 1.65
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs (1981) 1.64
Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs (1984) 1.64
Metoclopramide: a review of its pharmacological properties and clinical use. Drugs (1976) 1.63
Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs (1990) 1.61
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs (1980) 1.59
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1985) 1.56
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs (1981) 1.55
Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1986) 1.53
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs (1997) 1.52
Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1984) 1.52
Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs (1977) 1.52
Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 1.51
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs (1978) 1.48
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs (1995) 1.45
Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs (1978) 1.44
Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs (1994) 1.44
Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs (1995) 1.43
Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs (1980) 1.43
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1987) 1.43
Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs (1988) 1.41
Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1994) 1.40
Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. Drugs (1978) 1.40
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1986) 1.39
Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting. Pharmacoeconomics (1996) 1.39
Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs (1975) 1.38
Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1978) 1.37
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1990) 1.36
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs (1989) 1.35
Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy. Drugs (1981) 1.33
Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs (1979) 1.32
Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs (1993) 1.30
Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs (1990) 1.29
Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1979) 1.29
Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs (1992) 1.28
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1984) 1.26
Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs (1978) 1.23
Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs (1980) 1.22
Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma. Drugs (1978) 1.22
Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1982) 1.22
Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs (1975) 1.21
Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs (1991) 1.18
Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs (1974) 1.18
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs (1983) 1.17
Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs (1991) 1.17
Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs (1987) 1.17
Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs (1976) 1.16
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs (1987) 1.16
Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1978) 1.14
Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 1.13
Butorphanol: a review of its pharmacological properties and therapeutic efficacy. Drugs (1978) 1.13
Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs (1981) 1.13
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs (1990) 1.12
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs (1983) 1.12
Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs (1976) 1.12
Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1981) 1.11
Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs (1988) 1.11
Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs (1984) 1.11
Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs (1983) 1.11
Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer. Drugs (1976) 1.10
Diltiazem. A review of its pharmacological properties and therapeutic efficacy. Drugs (1985) 1.10
Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy. Drugs (1982) 1.10
Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs (1990) 1.09
Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1979) 1.09
Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs (1984) 1.08
Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. Drugs (1998) 1.08
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs (1992) 1.08
Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs (1977) 1.08
Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs (1989) 1.08